These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7561161)

  • 1. Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes.
    Rao CN; Ladin DA; Liu YY; Chilukuri K; Hou ZZ; Woodley DT
    J Invest Dermatol; 1995 Oct; 105(4):572-8. PubMed ID: 7561161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin.
    Grinnell F; Zhu M
    J Invest Dermatol; 1994 Aug; 103(2):155-61. PubMed ID: 8040604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin.
    Grinnell F; Zhu M
    J Invest Dermatol; 1996 Feb; 106(2):335-41. PubMed ID: 8601737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin-C degradation in chronic wounds is dependent on serine proteinase activity.
    Latijnhouwers MA; Bergers M; Veenhuis RT; Beekman B; Ankersmit-Ter Horst MF; Schalkwijk J
    Arch Dermatol Res; 1998 Sep; 290(9):490-6. PubMed ID: 9808342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wound fluids and the pathogenesis of chronic wounds.
    Wysocki AB
    J Wound Ostomy Continence Nurs; 1996 Nov; 23(6):283-90. PubMed ID: 9043277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays.
    Grinnell F; Ho CH; Wysocki A
    J Invest Dermatol; 1992 Apr; 98(4):410-6. PubMed ID: 1372338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncontrolled gelatin degradation in non-healing chronic wounds.
    Trøstrup H; Holstein P; Karlsmark T; Moser C; Ågren MS
    J Wound Care; 2018 Nov; 27(11):724-734. PubMed ID: 30398935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers.
    Schmidtchen A
    Acta Derm Venereol; 2000 May; 80(3):179-84. PubMed ID: 10954207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation.
    Herrick S; Ashcroft G; Ireland G; Horan M; McCollum C; Ferguson M
    Lab Invest; 1997 Sep; 77(3):281-8. PubMed ID: 9314951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin profiles in normal and chronic wound fluid.
    Wysocki AB; Grinnell F
    Lab Invest; 1990 Dec; 63(6):825-31. PubMed ID: 2255189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory leucocyte proteinase inhibitor: inhibition of fibronectin degradation by neutrophil elastase.
    Gervaix A; Thompson R; Bieth JG; Nick HP; Suter S
    Eur Respir J; 1992 May; 5(5):566-75. PubMed ID: 1351853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.
    Trøstrup H; Lundquist R; Christensen LH; Jorgensen LN; Karlsmark T; Haab BB; Agren MS
    Br J Dermatol; 2011 Aug; 165(2):292-301. PubMed ID: 21517798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds.
    Chambers L; Woodrow S; Brown AP; Harris PD; Phillips D; Hall M; Church JC; Pritchard DI
    Br J Dermatol; 2003 Jan; 148(1):14-23. PubMed ID: 12534589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wound fluids: a reflection of the state of healing.
    Staiano-Coico L; Higgins PJ; Schwartz SB; Zimm AJ; Goncalves J
    Ostomy Wound Manage; 2000 Jan; 46(1A Suppl):85S-93S; quiz 94S-95S. PubMed ID: 10732643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The electrophoretic mobility of alpha 1-antitrypsin in sputum and its relationship to protease inhibitory capacity, leucocyte elastase concentrations and acute respiratory infection.
    Burnett D; Stockley RA
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):781-9. PubMed ID: 6968711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wound fluid from venous leg ulcers degrades plasminogen and reduces plasmin generation by keratinocytes.
    Hoffman R; Starkey S; Coad J
    J Invest Dermatol; 1998 Dec; 111(6):1140-4. PubMed ID: 9856830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation.
    Llewellyn-Jones CG; Lomas DA; Stockley RA
    Thorax; 1994 Jun; 49(6):567-72. PubMed ID: 7912452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocytosis and degradation of alpha 1-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor.
    Perlmutter DH; Joslin G; Nelson P; Schasteen C; Adams SP; Fallon RJ
    J Biol Chem; 1990 Oct; 265(28):16713-6. PubMed ID: 2211587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of alpha-1-antitrypsin with soluble and sepharose-bound elastase.
    Lo TN; Cohen AB; James HL
    Biochim Biophys Acta; 1976 Dec; 453(2):345-56. PubMed ID: 1087162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Matrix metalloproteinases MMP-2 and MMP-9 of wound and burn exudates and their effect on extracellular matrix proteins].
    Voronkina IV; Kokorin KV; Chulikov OV; Paramonov BA; Blinova MI; Pinaev GP
    Tsitologiia; 2003; 45(1):43-50. PubMed ID: 12683235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.